Clinical Trials Directory

Trials / Completed

CompletedNCT01382576

Women With Polycystic Ovary Syndrome Have Increased Plasma Chitotriosidase Activity

Women With Polycystic Ovary Syndrome Have Increased Plasma Chitotriosidase Activity: A Pathophysiological Link Between Inflammation and Impaired Insulin Sensitivity?

Status
Completed
Phase
Study type
Observational
Enrollment
78 (actual)
Sponsor
Gulhane School of Medicine · Academic / Other
Sex
Female
Age
18 Years – 35 Years
Healthy volunteers
Accepted

Summary

In the present study, serum chitotriosidase activity and its relationship with insulin resistance were determined in patients with Polycystic Ovary Syndrome (PCOS).

Detailed description

ChT activity is increased in patients with PCOS in concordance with insulin resistance. These findings may reflect the pronounced risk for metabolic syndrome and atherosclerotic diseases in this particular patient group.

Conditions

Timeline

Start date
2010-01-01
Primary completion
2010-12-01
Completion
2010-12-01
First posted
2011-06-27
Last updated
2012-03-12

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT01382576. Inclusion in this directory is not an endorsement.

Women With Polycystic Ovary Syndrome Have Increased Plasma Chitotriosidase Activity (NCT01382576) · Clinical Trials Directory